Cargando…
JAK2 p.G571S in B-cell precursor acute lymphoblastic leukemia: a synergizing germline susceptibility
Autores principales: | Lin, Minhui, Nebral, Karin, Gertzen, Christoph G. W., Ganmore, Ithamar, Haas, Oskar A., Bhatia, Sanil, Fischer, Ute, Kuhlen, Michaela, Gohlke, Holger, Izraeli, Shai, Trka, Jan, Hu, Jianda, Borkhardt, Arndt, Hauer, Julia, Auer, Franziska |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756027/ https://www.ncbi.nlm.nih.gov/pubmed/30967616 http://dx.doi.org/10.1038/s41375-019-0459-z |
Ejemplares similares
-
The role of the Exon 13 G571S JAK2 mutation in myeloproliferative neoplasms
por: Bahar, Burak, et al.
Publicado: (2016) -
Hsa-mir-125b-2 is highly expressed in childhood ETV6/RUNX1 (TEL/AML1) leukemias and confers survival advantage to growth inhibitory signals independent of p53
por: Gefen, Nir, et al.
Publicado: (2009) -
Regional BCG vaccination policy in former East- and West Germany may impact on both severity of SARS-CoV-2 and incidence of childhood leukemia
por: Hauer, Julia, et al.
Publicado: (2020) -
Cancer susceptibility syndromes in children in the area of broad clinical use of massive parallel sequencing
por: Kuhlen, Michaela, et al.
Publicado: (2015) -
Trio sequencing in pediatric cancer and clinical implications
por: Kuhlen, Michaela, et al.
Publicado: (2018)